278.28 0.00 (0.00%)
Pre-Market: 8:30AM EDT
|Bid||278.45 x 1000|
|Ask||285.00 x 1000|
|Day's Range||271.95 - 280.39|
|52 Week Range||225.65 - 355.88|
|Beta (3Y Monthly)||1.09|
|PE Ratio (TTM)||15.20|
|Earnings Date||Nov 5, 2019 - Nov 11, 2019|
|Forward Dividend & Yield||2.20 (0.79%)|
|1y Target Est||333.95|
In 2019, insurance companies will be widening their Affordable Care Act plan offerings, expanding their roster of states to places like Pennsylvania, Georgia, and Nebraska, where the options have been limited. Yahoo Finance's Anjalee Khemlani joins The First Trade to discuss.
The pilot allows Humana At Home care management teams to connect digitally with the most vulnerable Medicare Advantage members and their caregivers. The pilot is designed to allow Humana At Home care management teams to connect digitally with Humana Medicare Advantage members and their families, so that members with medical and functional challenges can maintain their independence and receive support at home.
Banking on a rising revenue base and an inorganic growth strategy, Centene (CNC) holds enough potential to reap benefits for investors.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Louisville Healthcare CEO Council is taking major steps forward with a new strategic plan and a new chairman. The group is made up of 10 of the area's most prominent health care CEOs. Joe Steier, a member of the council and CEO of long-term-care provider Signature Healthcare Inc., will lead the development of the investment fund in partnership with an already-established capital investment committee which is led by Michael Bryant, the chief operating officer of senior Trilogy Health Service Inc., a senior care and housing provider. The innovation center will be overseen by William Altman, former chief strategy officer for Kindred Healthcare. Altman acts as senior advisor of strategy to the council. Council CEO and president Tammy York Day will oversee the creation of the international aging innovation center, a news release states. A new chairman of the council Kindred Healthcare LLC president and CEO Ben Breier will now be the chairman for the group.
The sector has lagged behind the broader market, partly because of concern that the government could act to rein in drug prices.
Riding on increasing membership and inorganic growth strategies, WellCare Health (WCG) holds potential to reap benefits for investors. Besides, the company inks a merger deal with Centene in 2020.
Humana's venture with a Boston-based primary care provider has expanded access to specialized primary care clinics.
Humana Pharmacy, a division of Humana Inc. (HUM), has been named the top U.S. Mail Order Pharmacy in customer satisfaction in the J.D. Power 2019 U.S. Pharmacy Study, two years in a row. Humana Pharmacy’s score of 900 this year was the highest among Mail Order pharmacies.
Humana Medicare Advantage members have additional access to high-impact, relationship-based primary care thanks to Iora Health and Humana Inc. (HUM) teaming up to add 11 additional Iora Primary Care practices to Humana’s Medicare Advantage network in Arizona, Georgia and Texas. Iora Primary Care is the consumer brand of Iora Health.
Waived all requirements for primary care physician (PCP) referrals and prior authorizations for members in counties declared disaster areas. Humana has counselors and Work-Life specialists available 24 hours a day, seven days a week at 1-888-673-1154 (TTY:711) to provide free, confidential assistance to anyone needing help and support in coping with the disaster and its aftermath. Humana Medicare, Medicaid, commercial and TRICARE members with questions about services available to them should call the toll-free phone number on the back of their Humana ID card.
The partnership is the first of its kind for Ascension, which operates 151 hospitals across the country.
Grand Blanc-based McLaren Physician Partners and leading health and well-being company Humana Inc. have signed an agreement that expands in-network options for Humana Medicare Advantage members in Michigan seeking care at McLaren Health Care hospitals and outpatient facilities.
Humana Inc. announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the Wells Fargo Healthcare Conference on Wednesday, September 4, 2019, at 9:40 a.m.
The Healthcare Transformation Alliance, led by former N.J. Congressman Rob Andrews, has saved its members at least $400 million in overall health care spending.
Mays Business School at Texas A&M University and health and well-being company Humana Inc. are launching the 2019 Humana-Mays Healthcare Analytics Case Competition to showcase students’ analytical abilities to solve a real-world business problem.
Humana Inc. announced today that its Board of Directors has declared a cash dividend to stockholders of $0.55 per share payable on October 25, 2019 to stockholders of record as of the close of business on September 30, 2019.
(Bloomberg Opinion) -- By all accounts, it was supposed to be a sleepy August for the U.S. corporate bond market. Three weeks ago, the thinking went something like this: Sure, the Federal Reserve would cut its benchmark lending rate on July 31, in what Chair Jerome Powell would call a “mid-cycle adjustment.” But Treasuries were already pricing in such a move on the short end. Further out on the curve, the 30-year yield was about 2.6%, still more than 50 basis points away from its all-time low. Ten-year yields were about 2%, which seemed like a comfortable range for both buyers and sellers. For company finance officers, it had the makings of a sellers’ market but one that would be around once summer drew to a close.Then things got crazy. The 30-year yield lurched lower by 8 basis points on Aug. 1, then 13 basis points on Aug. 5, then another 13 basis points on Aug. 12. After a one-day reprieve near its all-time low of 2.0882%, it cruised through that level, tumbling to as low as 1.914%. The rally was so intense that the U.S. Treasury Department made an unusual, unscheduled announcement that it was again exploring issuing 50- or 100-year bonds. Companies clearly felt they couldn’t afford to pass up this opportunity. In the first full week of August, CVS Health Corp., Humana Inc. and Welltower Inc. headlined $35 billion of debt sales among investment-grade firms, easily surpassing estimates. Then in the week through Aug. 16, more than $22 billion went through, including a rarely seen offering from Exxon Mobil to the tune of $7 billion. Market watchers expected that would just about wrap things up until after Labor Day on Sept. 2.Some finance officers had other ideas. 3M Co. borrowed $3.25 billion on Monday to help finance its acquisition of medical-products maker Acelity Inc. In total, issuers sold $6.65 billion of investment-grade debt on Aug. 19, already topping some predictions for $5 billion this week. Then on Tuesday, Bank of New York Mellon Corp. priced $1 billion at the lower end of its expected yield range, along with a handful of other borrowers with multimillion-dollar deals.All this is to say, companies are simple: They see staggering low yields, and they issue bonds. Investors, for their part, can’t get enough of them. The Bloomberg Barclays U.S. Corporate Bond Index has returned 13.3% so far in 2019. Over the past 12 months, the index is up 12.5%, compared with just 1.5% for the S&P 500 Index. The average spread on corporate bonds has widened to 122 basis points, from 107 basis points at the end of July, but that’s just because they couldn’t keep up with the relentless rally in Treasuries, not because of a lack of buyers. If Bank of America Corp. strategists led by Hans Mikkelsen are correct, the demand in credit markets has lasting power. They say the $16 trillion of negative-yielding debt globally has left investors — and particularly those outside the U.S. — with few alternatives besides purchasing companies’ debt. “There is a wall of new money being forced into the global corporate bond market,” they wrote on Aug. 16. “Given the near extinction of non-USD IG yield, foreign investors are forced to take more risk.”Of course, buying investment-grade bonds hardly qualifies as a speculative endeavor. Exxon Mobil, in fact, has the same credit rating as the U.S. government from both Moody’s Investors Service and S&P Global Ratings. On the other hand, Bloomberg News’s Jeannine Amodeo and Davide Scigliuzzo reported this week that three leveraged-loan sales that had been languishing in the U.S. market for weeks were pulled as investors sought higher-quality assets. Vewd Software became the fourth on Tuesday, scrapping a $125 million term loan due to market conditions. Leveraged loans, it should be noted, are floating-rate securities and so face weaker demand when the Fed appears poised to cut rates, as it does now. But for large, highly rated companies, their behavior in recent weeks is exactly what should be expected. Exxon Mobil issued 30-year bonds to yield 3.095%. In November, five-year Treasuries offered the same amount. 3M, rated a few steps below triple-A, priced 30-year debt to yield 3.37%, less than the going rate on long Treasury bonds just nine months ago. No matter how you slice it, they’re getting borrowing costs that seemed unthinkable around this time last year.Interestingly, these low yields should be encouraging governments to borrow more, too. I wrote last week that the bond markets were begging for infrastructure spending. However, it seems neither Germany nor the U.S. has any appetite for that sort of initiative. The German government is reportedly preparing fiscal stimulus that could be triggered by a deep recession, while President Donald Trump hasn’t ruled out a payroll tax cut to stave off any economic weakness.It’s certainly possible that U.S. yields will only fall further from here, and other companies can also borrow or refinance at rock-bottom interest rates. But the move in global bond markets in recent weeks could was extreme, to say the least. The weak demand for Germany’s 30-year bond auction on Wednesday, which offered a coupon of 0% at a yield of -0.11%, suggests there are at least some lines that investors won’t cross.For prudent companies, it was well worth delaying summer vacations to get their deals done.To contact the author of this story: Brian Chappatta at firstname.lastname@example.orgTo contact the editor responsible for this story: Daniel Niemi at email@example.comThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brian Chappatta is a Bloomberg Opinion columnist covering debt markets. He previously covered bonds for Bloomberg News. He is also a CFA charterholder.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.